C

China Baoan Group Co Ltd
SZSE:000009

Watchlist Manager
China Baoan Group Co Ltd
SZSE:000009
Watchlist
Price: 9.5 CNY -0.21% Market Closed
Market Cap: 24.5B CNY
Have any thoughts about
China Baoan Group Co Ltd?
Write Note

Net Margin
China Baoan Group Co Ltd

2.2%
Current
4%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.2%
=
Net Income
463.3m
/
Revenue
20.8B

Net Margin Across Competitors

Country CN
Market Cap 24.5B CNY
Net Margin
2%
Country US
Market Cap 182.2B USD
Net Margin
13%
Country DE
Market Cap 149.5B EUR
Net Margin
11%
Country US
Market Cap 148.5B USD
Net Margin
15%
Country JP
Market Cap 17.8T JPY
Net Margin
7%
Country ZA
Market Cap 93.3B Zac
Net Margin
5%
Country US
Market Cap 70.4B USD
Net Margin
17%
Country US
Market Cap 53.8B EUR
Net Margin
22%
Country CN
Market Cap 254.5B HKD
Net Margin
8%
Country IN
Market Cap 2.4T INR
Net Margin
12%
Country HK
Market Cap 155.5B HKD
Net Margin
8%
No Stocks Found

China Baoan Group Co Ltd
Glance View

Market Cap
24.5B CNY
Industry
Industrial Conglomerates

China Baoan Group Co., Ltd., established in 1983, has evolved into a dynamic conglomerate that seamlessly merges tradition with innovation. Rooted initially in the real estate sector, the company expanded its horizons over the decades, venturing into a diverse array of industries. Today, its portfolio encompasses pharmaceuticals, new materials, and high-technology ventures, each segment contributing its distinct thread to the company's rich tapestry. Real estate remains a foundational pillar of its operations, providing a steady revenue base through the development and management of commercial and residential properties across China. With strategic diversification, the company has maneuvered through economic cycles, skillfully leveraging its core competencies to unlock new growth avenues. Beyond the bricks and mortar, China Baoan's venture into pharmaceuticals and new materials signifies its adaptability and pursuit of future-ready sectors. In the pharmaceutical realm, it channels resources into research and development, producing advanced medical solutions and healthcare products that meet the growing demands of the domestic market. Meanwhile, its development of new materials, particularly in lithium-ion batteries and related technologies, aligns with global transitions towards sustainable energy. This sector not only complements its real estate development by aiding innovation in construction materials but also taps into the burgeoning electric vehicle industry, thus opening new revenue streams. Through this intricate blend of legacy and futurism, China Baoan Group crafts its narrative as a versatile power in China's ever-evolving economic landscape, continually seeking opportunities to enhance its footprint both domestically and abroad.

Intrinsic Value
6 CNY
Overvaluation 37%
Intrinsic Value
Price
C

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.2%
=
Net Income
463.3m
/
Revenue
20.8B
What is the Net Margin of China Baoan Group Co Ltd?

Based on China Baoan Group Co Ltd's most recent financial statements, the company has Net Margin of 2.2%.